Nikolaus B. Binder

1.6k total citations
31 papers, 954 citations indexed

About

Nikolaus B. Binder is a scholar working on Hematology, Immunology and Molecular Biology. According to data from OpenAlex, Nikolaus B. Binder has authored 31 papers receiving a total of 954 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Hematology, 12 papers in Immunology and 8 papers in Molecular Biology. Recurrent topics in Nikolaus B. Binder's work include Platelet Disorders and Treatments (8 papers), Complement system in diseases (7 papers) and Bone Metabolism and Diseases (6 papers). Nikolaus B. Binder is often cited by papers focused on Platelet Disorders and Treatments (8 papers), Complement system in diseases (7 papers) and Bone Metabolism and Diseases (6 papers). Nikolaus B. Binder collaborates with scholars based in United States, Germany and Austria. Nikolaus B. Binder's co-authors include Birgit Niederreiter, Kurt Redlich, Josef S Smolen, Peter L. Turecek, Richard Stange, Matthias Mack, Stephan Schwers, Thomas Pap, Reinhold G. Erben and Thomas M. Stulnig and has published in prestigious journals such as Journal of Clinical Investigation, Nature Medicine and Blood.

In The Last Decade

Nikolaus B. Binder

30 papers receiving 933 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Nikolaus B. Binder United States	14	309	279	228	191	165	31	954
Ki‐Jo Kim South Korea	18	250 0.8×	237 0.8×	64 0.3×	416 2.2×	130 0.8×	56	1.0k
Hirofumi Taki Japan	19	318 1.0×	191 0.7×	205 0.9×	263 1.4×	48 0.3×	76	1.1k
Chia‐Wei Hsieh Taiwan	19	240 0.8×	420 1.5×	85 0.4×	418 2.2×	332 2.0×	48	1.1k
Takahiro Matsui Japan	19	313 1.0×	155 0.6×	271 1.2×	126 0.7×	40 0.2×	91	1.1k
J. G. Saal Germany	16	156 0.5×	224 0.8×	149 0.7×	418 2.2×	105 0.6×	45	1.1k
Takayasu Ito Japan	14	267 0.9×	70 0.3×	215 0.9×	199 1.0×	47 0.3×	88	1.1k
Mohammadhadi Bagheri United States	19	247 0.8×	122 0.4×	404 1.8×	68 0.4×	59 0.4×	66	1.5k
Sang‐Heon Lee South Korea	22	274 0.9×	678 2.4×	331 1.5×	947 5.0×	283 1.7×	106	1.8k

Countries citing papers authored by Nikolaus B. Binder

Since Specialization

Citations

This map shows the geographic impact of Nikolaus B. Binder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nikolaus B. Binder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nikolaus B. Binder more than expected).

Fields of papers citing papers by Nikolaus B. Binder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nikolaus B. Binder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nikolaus B. Binder. The network helps show where Nikolaus B. Binder may publish in the future.

Co-authorship network of co-authors of Nikolaus B. Binder

This figure shows the co-authorship network connecting the top 25 collaborators of Nikolaus B. Binder. A scholar is included among the top collaborators of Nikolaus B. Binder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nikolaus B. Binder. Nikolaus B. Binder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Verbruggen, Bert, et al.. (2024). Development of a rapid and fully automated factor VIII inhibitor assay, insensitive to emicizumab, and a lowest level of quantification of 0.2 BU/mL. Journal of Thrombosis and Haemostasis. 22(10). 2745–2751. 1 indexed citations

Verbruggen, Bert, Gary Moore, & Nikolaus B. Binder. (2024). Precision study of a fast and fully automated FVIII functional inhibitor test. Hämostaseologie.

Hoydis, Jakob, Fayçal Ait Aoudia, Sebastian Cammerer, et al.. (2023). Sionna RT: Differentiable Ray Tracing for Radio Propagation Modeling. 317–321. 69 indexed citations

Moore, Gary, et al.. (2023). ADAMTS13 Antibody and Inhibitor Assays. Methods in molecular biology. 2663. 549–565. 10 indexed citations

Moore, Gary, Margaret A. Griffiths, & Nikolaus B. Binder. (2023). ADAMTS13 Activity: Screening Test Protocol. Methods in molecular biology. 2663. 523–531. 2 indexed citations

Studt, Jan–Dirk, Lorenzo Alberio, Pierre Fontana, et al.. (2023). Determination of Anti-Xa Inhibitor Plasma Concentrations Using a Universal Edoxaban Calibrator. Diagnostics. 13(12). 2128–2128. 1 indexed citations

Egger, Alexander, Sabina Sahanic, Andreas Gleiß, et al.. (2022). One-Year Follow-Up of COVID-19 Patients Indicates Substantial Assay-Dependent Differences in the Kinetics of SARS-CoV-2 Antibodies. Microbiology Spectrum. 10(6). e0059722–e0059722. 6 indexed citations

Pasternack, Ralf, et al.. (2021). Clinical Validation of an Automated Fluorogenic Factor XIII Activity Assay Based on Isopeptidase Activity. International Journal of Molecular Sciences. 22(3). 1002–1002. 7 indexed citations

Binder, Nikolaus B., et al.. (2021). Clinical use of thrombin generation assays. Journal of Thrombosis and Haemostasis. 19(12). 2918–2929. 69 indexed citations

10.

Turecek, Peter L., Savita Rangarajan, Michael Laffan, et al.. (2021). Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19. Thrombosis Research. 201. 100–112. 34 indexed citations

11.

Pasternack, Ralf, et al.. (2020). Feasibility of an automated coagulation factor XIIIa test using its isopeptidase activity. Analytical Biochemistry. 600. 113757–113757. 2 indexed citations

12.

Binder, Nikolaus B., et al.. (2019). Performance Evaluation of the New Screening Assay for ADAMTS-13 Activity. Hämostaseologie. 2 indexed citations

13.

Binder, Nikolaus B., Antonia Puchner, Birgit Niederreiter, et al.. (2012). Tumor necrosis factor–inhibiting therapy preferentially targets bone destruction but not synovial inflammation in a tumor necrosis factor–driven model of rheumatoid arthritis. Arthritis & Rheumatism. 65(3). 608–617. 47 indexed citations

14.

Goldring, Steven R., P. Edward Purdue, Tania N. Crotti, et al.. (2012). Bone remodelling in inflammatory arthritis. Annals of the Rheumatic Diseases. 72. ii52–ii55. 44 indexed citations

15.

Binder, Nikolaus B., K. Adam Bohnert, Bryan J. Nestor, et al.. (2012). Orthopedic wear debris mediated inflammatory osteolysis is mediated in part by NALP3 inflammasome activation. Journal of Orthopaedic Research®. 31(1). 73–80. 84 indexed citations

16.

Blüml, Stephan, Nikolaus B. Binder, Birgit Niederreiter, et al.. (2010). Antiinflammatory effects of tumor necrosis factor on hematopoietic cells in a murine model of erosive arthritis. Arthritis & Rheumatism. 62(6). 1608–1619. 59 indexed citations

17.

Blüml, Stephan, Nikolaus B. Binder, Birgit Niederreiter, et al.. (2010). Analysis of TNFR2-mediated functions on osteoclast precursor cells. Annals of the Rheumatic Diseases. 69. A35–A36. 2 indexed citations

18.

Binder, Nikolaus B., Birgit Niederreiter, Oskar Hoffmann, et al.. (2009). Estrogen-dependent and C-C chemokine receptor-2–dependent pathways determine osteoclast behavior in osteoporosis. Nature Medicine. 15(4). 417–424. 160 indexed citations

19.

Karonitsch, Thomas, Eva Feierl, Carl W. Steiner, et al.. (2009). Activation of the interferon‐γ signaling pathway in systemic lupus erythematosus peripheral blood mononuclear cells. Arthritis & Rheumatism. 60(5). 1463–1471. 77 indexed citations

20.

Parker, L M, et al.. (1982). Effect of acyclovir and interferon on human hematopoietic progenitor cells. Antimicrobial Agents and Chemotherapy. 21(1). 146–150. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact